Stocks›Healthcare›ILMN

ILMN Illumina, Inc.

NasdaqResearch view

Illumina, Inc. operates in the Laboratory Analytical Instruments industry.

$262.54−2.01%

Oct 16 close · 1D EOD · Databento

HealthcareLaboratory Analytical InstrumentsLarge-capSEC EDGAR FY 2025-12-28

On the WireNo stories on ILMN yet. Follow the company and the next one lands in Following.

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 30, 2025 and Nov 4, 2024, after the close.

Last report

Jul 30, 20260.00%

after the close

Last 4, next close

median 8.77% either way

up 2 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Jul 30Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗0.00%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

12 big days in a year, and what we hold on each

A big day is a close more than 5.44% from the one before, three times ILMN’s median day (1.81%). On 2 of the 12, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±5.44%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayILMNWhat we hold that dayGroup (median of 4) · each

1 Oct 31, 2025+24.78%
Resultsgroup +2.5%, did not move with it
1Oct 31, 2025+24.78%
ResultsFirst close after the Oct 30 results filing
+2.5% did not move with itMTD +2.9 · RVTY +2.8 · A +2.1 · WAT +1.9
2 Feb 6, 2026−10.40%
Resultsgroup +0.6%, did not move with it
2Feb 6, 2026−10.40%
ResultsFirst close after the Feb 5 results filing
+0.6% did not move with itMTD −0.7 · A −0.1 · WAT +1.2 · RVTY +2.1
3 Feb 27, 2026+5.54%
Before our storiesgroup −0.7%, did not move with it
3Feb 27, 2026+5.54%
Before our stories
−0.7% did not move with itA +0.3 · RVTY −0.7 · MTD −0.8 · WAT −1.1
4 May 1, 2026+7.13%
Resultsgroup −0.7%, did not move with it
4May 1, 2026+7.13%
ResultsFirst close after the Apr 30 results filing
−0.7% did not move with itRVTY +0.1 · WAT −0.7 · MTD −0.8 · A −0.9
5 May 28, 2026+5.68%
Before our storiesgroup +6.8%, moved with ILMN
5May 28, 2026+5.68%
Before our stories
+6.8% moved with ILMNA +16.9 · WAT +7.2 · MTD +6.4 · RVTY +4.6
6 Jun 24, 2026+6.16%
Nothing on ILMNgroup +4.0%, moved with ILMN
6Jun 24, 2026+6.16%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
+4.0% moved with ILMNRVTY +5.7 · MTD +4.0 · A +3.9 · WAT +3.4
7 Aug 19, 2026+8.87%
Nothing on ILMNgroup +4.2%, did not move with it
7Aug 19, 2026+8.87%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
+4.2% did not move with itRVTY +5.0 · A +4.7 · WAT +3.6 · MTD +1.8
8 Sep 15, 2026+6.76%
Nothing on ILMNgroup +2.9%, did not move with it
8Sep 15, 2026+6.76%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
+2.9% did not move with itRVTY +9.1 · MTD +3.5 · A +2.4 · WAT +1.7
9 Sep 17, 2026+7.10%
Nothing on ILMNgroup +2.0%, did not move with it
9Sep 17, 2026+7.10%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
+2.0% did not move with itWAT +2.6 · MTD +2.3 · A +1.7 · RVTY +0.7
10 Sep 24, 2026+7.25%
Nothing on ILMNgroup +3.4%, did not move with it
10Sep 24, 2026+7.25%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
+3.4% did not move with itRVTY +6.0 · A +4.5 · WAT +2.3 · MTD +1.8
11 Oct 5, 2026+7.56%
Nothing on ILMNgroup +3.6%, did not move with it
11Oct 5, 2026+7.56%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
+3.6% did not move with itRVTY +3.9 · MTD +3.7 · WAT +3.5 · A +2.1
12 Oct 6, 2026−6.86%
Nothing on ILMNgroup −1.0%, did not move with it
12Oct 6, 2026−6.86%
Nothing on ILMNNo ILMN story, brief or results filing in our record that day
−1.0% did not move with itRVTY −2.6 · A −1.1 · WAT −0.8 · MTD −0.6

A story on the same day is not a cause, and a group move is not proof either. Group: the median of A, WAT, MTD and RVTY that day, the largest companies in ILMN’s SEC industry; “moved with ILMN” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). ILMN reports after the close, so day 1 is the next close. 3 of 4 times, day 6 ended on the same side as day 1.

Reported Oct 30, 2025

day 1+24.78%day 6+23.12%

Reported Feb 5, 2026

day 1−10.40%day 6−12.57%

Reported Apr 30, 2026

day 1+7.13%day 6+11.95%

Reported Jul 30, 2026

day 10.00%day 6−8.35%

Next report: expected late OctoberEstimated from the dates of its last four results filings. Not announced. Since the Jul 30 report: +28.01%. Four reports is a small sample.

Every report since 2023 →

Each line is ILMN’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$39.6B

Revenue$4.3B−0.70%

Net income$850.0M

EPS, diluted$5.45+170.90%

Gross margin66.1%

Operating margin18.6%

Return on equity31.2%

Debt / equity0.43

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-28

SectorHealthcare

Market Cap$39.6B

Enterprise Value$39.4B

Income$850.0M

Sales$4.3B

Book/sh$18.03

Cash/sh$9.39

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio1.72

Current Ratio2.08

Debt/Eq0.43

EPS (ttm)$5.45

EPS this Y170.9%

EPS past 3/5Y—

Sales past 3/5Y-1.8%

EPS Y/Y TTM170.9%

Sales Y/Y TTM-0.7%

Shs Outstand151.00M

ROA12.8%

ROE31.2%

ROIC25.5%

Gross Margin66.1%

Oper. Margin18.6%

Profit Margin19.6%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$4.5B

FY22

$4.6B

FY23

$4.5B

FY23

$4.4B

FY24

$4.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2022	FY2023	FY2023	FY2024	FY2025
Revenue	$4.5B	$4.6B	$4.5B	$4.4B	$4.3B
Gross Profit	$3.2B	$3.0B	$2.7B	$2.9B	$2.9B
Operating Income	$-123.0M	$-4.2B	$-1.1B	$-833.0M	$807.0M
Net Income	$762.0M	$-4.4B	$-1.2B	$-1.2B	$850.0M
Diluted EPS	$5.04	$-28.00	$-7.34	$-7.69	$5.45
Operating Cash Flow	$545.0M	$392.0M	$478.0M	$837.0M	$1.1B
Free Cash Flow	$337.0M	$106.0M	$283.0M	$709.0M	$931.0M

Same industry

ILMN against four same-industry peers, a year at 100

ILMN is up 2.8 times in a year. All four did less: Revvity (+63.4%), Waters (+30.6%), Agilent Technologies (+21.9%) and Mettler Toledo International Inc/ (+20.2%). Weekly closes, Oct 17, 2025 = 100, on a log scale so a 2.8-fold rise and a 20.2% rise both read honestly.

Share this chart

ILMN ×2.8. Revvity +63.4%, Waters +30.6%, Agilent Technologies +21.9%, Mettler Toledo International Inc/ +20.2%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ILMN’s SEC industry (Laboratory Analytical Instruments) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

A$48.9B WAT$42.9B MTD$32.5B RVTY$17.0B AVTR$11.1B BIO$9.6B TXG$8.7B BRKR$8.3B

Build basket with ILMN Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.